Response to Hydroxyurea in a Patient With Sickle Cell Hepatopathy: A Case Report

Sickle cell hepatopathy is an underreported entity lacking clear management guidelines. This case highlights the potential role of hydroxyurea (HU) in improving the hepatic dysfunction seen among patients with sickle cell disease (SCD). We herein present the clinical course of a patient prior to and...

Descripción completa

Detalles Bibliográficos
Autores principales: Safhi, Maha A, Baghdadi, Rana M, Al-Marzouki, Adel F, Al-Sayes, Fatin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Hematology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712197/
https://www.ncbi.nlm.nih.gov/pubmed/34976545
http://dx.doi.org/10.7759/cureus.20649

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8712197/
https://www.ncbi.nlm.nih.gov/pubmed/34976545
http://dx.doi.org/10.7759/cureus.20649

Ejemplares similares